Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Iain Miller, Joseph Slattery

Premium

Iain Miller has established Healthcare Strategies Group, a London-based organization that provides strategic advisory services to life sciences tools firms and pharmaceutical companies.

Miller is involved in several international policy initiatives, including The European Personalized Medicine association, where he serves as a board member.

Previously, Miller worked at GE Healthcare as the global head of personalized healthcare strategy and partnerships. While at BioMerieux, Miller was senior director of oncology strategy and theranostics, and led strategy and business development activities within the company's personalized medicine business unit.


Exosome Diagnostics has appointed Joseph Slattery to its board of directors.

Slattery is CFO and executive VP of Baxano Surgical. Prior to Baxano, Slattery was CFO and senior VP of the molecular diagnostics firm Digene.

Filed under

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.